Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriserede Fysioterapeuter FysioDanmark Skive ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.1% 2.9% 4.9% 2.4% 1.9% 1.6% 4.9% 4.9%   Credit score (0-100)   87 59 44 62 69 73 44 44   Credit rating   A BBB BBB BBB A A BBB BBB   Credit limit (kDKK)   171.1 0.0 0.0 0.0 0.5 4.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,819 5,709 4,667 6,273 5,917 6,545 0.0 0.0   EBITDA   2,252 774 231 1,046 1,260 1,437 0.0 0.0   EBIT   1,333 -175 -721 64.7 389 595 0.0 0.0   Pre-tax profit (PTP)   1,003.9 -374.8 -923.7 -125.7 189.3 106.2 0.0 0.0   Net earnings   751.7 -292.3 -720.6 -98.0 121.4 84.9 0.0 0.0   Pre-tax profit without non-rec. items   1,004 -375 -924 -126 189 106 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,415 1,142 943 405 166 5,625 0.0 0.0   Shareholders equity total   2,114 1,672 951 853 975 1,060 1,010 1,010   Interest-bearing liabilities   7,983 7,588 7,469 6,745 5,863 10,415 4,886 4,886   Balance sheet total (assets)   11,373 10,331 9,428 8,316 7,682 12,385 5,895 5,895   Net Debt   7,980 7,586 7,455 6,729 5,858 10,406 4,886 4,886     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,819 5,709 4,667 6,273 5,917 6,545 0.0 0.0   Gross profit growth   442.3% -1.9% -18.3% 34.4% -5.7% 10.6% -100.0% 0.0%   Employees   8 13 12 11 10 11 0 0   Employee growth %   700.0% 62.5% -7.7% -8.3% -9.1% 10.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,373 10,331 9,428 8,316 7,682 12,385 5,895 5,895   Balance sheet change%   569.5% -9.2% -8.7% -11.8% -7.6% 61.2% -52.4% 0.0%   Added value   2,252.0 774.5 230.8 1,046.1 1,370.6 1,436.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   8,125 -1,854 -1,783 -2,151 -1,742 3,985 -5,625 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.9% -3.1% -15.5% 1.0% 6.6% 9.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.4% -1.5% -7.3% 0.8% 4.9% 6.0% 0.0% 0.0%   ROI %   22.1% -1.7% -7.8% 0.8% 5.3% 6.5% 0.0% 0.0%   ROE %   43.2% -15.4% -54.9% -10.9% 13.3% 8.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.6% 16.2% 10.1% 10.3% 12.7% 8.6% 17.1% 17.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   354.3% 979.5% 3,229.8% 643.2% 464.9% 724.2% 0.0% 0.0%   Gearing %   377.6% 453.9% 785.2% 790.5% 601.5% 983.0% 483.9% 483.9%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.3% 2.7% 2.7% 2.7% 3.2% 6.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.2 0.2 0.2 0.3 0.3 0.0 0.0   Current Ratio   0.4 0.3 0.2 0.3 0.4 0.3 0.0 0.0   Cash and cash equivalent   3.6 1.9 14.6 15.3 4.7 9.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,298.1 -1,757.6 -2,112.7 -1,574.0 -1,361.3 -1,740.1 -2,442.8 -2,442.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   281 60 19 95 137 131 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   281 60 19 95 126 131 0 0   EBIT / employee   167 -13 -60 6 39 54 0 0   Net earnings / employee   94 -22 -60 -9 12 8 0 0